NCT05269069View on ClinicalTrials.gov

Impact of Rheumatoid Arthritis on Body Composition, Bone Marrow Adiposity and Bone Mineral Density: a Case-control Study

TerminatedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

August 17, 2022

Primary Completion Date

April 2, 2024

Study Completion Date

April 2, 2024

Conditions
Rheumatoid Arthritis
Interventions
OTHER

Assessment of body composition, bone mineral density and bone marrow adiposity.

DXA for body composition and bone mineral density, MRI for bone marrow adiposity and blood tests (leptine, CTX, P1NP)

Trial Locations (1)

Unknown

Hop Salengro - Chu Lille, Lille

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Hospital, Lille

OTHER

NCT05269069 - Impact of Rheumatoid Arthritis on Body Composition, Bone Marrow Adiposity and Bone Mineral Density: a Case-control Study | Biotech Hunter | Biotech Hunter